Central retinal vein occlusion risk profile: a case-control study
- PMID: 12841567
- DOI: 10.1177/112067210301300505
Central retinal vein occlusion risk profile: a case-control study
Abstract
Purpose: To identify risk factors for central retinal vein occlusion (CRVO).
Methods: This clinic-based case-control study included 408 patients with CRVO aged 21 years and older and 566 controls who were seen between January 1, 1990, and December 31, 2001. Multivariate logistic regression analysis was used to adjust for various factors and test potential interactions between the different variables.
Results: An increased risk of CRVO was found in persons with systemic hypertension, but odds ratios were greater for older patients. Risk of CRVO increases with age and also in association with hypercoagulability. Diabetes mellitus, kidney disease, and glaucoma were associated with increased risk for CRVO. A significantly greater prevalence of higher erythrocyte sedimentation rate was present in young adults compared with older patients.
Conclusions: The results suggest a relationship between CRVO and certain risk factors (systemic hypertension, diabetes mellitus, kidney disease, glaucoma, older age) and support the possibility of an association between CRVO and urban location. The findings also support the potential value of medical treatment of underlying medical conditions in preventing occurrence of CRVO.
Similar articles
-
Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.Arch Ophthalmol. 1996 May;114(5):545-54. Arch Ophthalmol. 1996. PMID: 8619763
-
Retinal vein occlusion in Armenia.Eur J Ophthalmol. 1999 Jul-Sep;9(3):196-201. doi: 10.1177/112067219900900306. Eur J Ophthalmol. 1999. PMID: 10544974
-
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study.Ophthalmology. 1998 May;105(5):765-71. doi: 10.1016/S0161-6420(98)95012-6. Ophthalmology. 1998. PMID: 9593373
-
Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach.Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):308-11. doi: 10.1159/000073587. Pathophysiol Haemost Thromb. 2002. PMID: 13679663 Review.
-
[Risk factors in central retinal vein occlusion].Oftalmologia. 2011;55(2):27-37. Oftalmologia. 2011. PMID: 21888066 Review. Romanian.
Cited by
-
Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform.J Ophthalmol. 2017;2017:5601786. doi: 10.1155/2017/5601786. Epub 2017 Jul 24. J Ophthalmol. 2017. PMID: 28811936 Free PMC article.
-
Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion.Eye (Lond). 2013 Jul;27(7):816-22. doi: 10.1038/eye.2013.79. Epub 2013 Apr 19. Eye (Lond). 2013. PMID: 23598674 Free PMC article.
-
Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S27-S31. doi: 10.4103/ijo.IJO_1934_19. Indian J Ophthalmol. 2020. PMID: 31937725 Free PMC article.
-
A longitudinal analysis of risk factors associated with central retinal vein occlusion.Ophthalmology. 2013 Feb;120(2):362-70. doi: 10.1016/j.ophtha.2012.07.080. Epub 2012 Nov 20. Ophthalmology. 2013. PMID: 23177364 Free PMC article.
-
Association between retinal vein occlusion and early-stage hypertension: A propensity score analysis using a large claims database.Eye (Lond). 2023 Jun;37(8):1741-1747. doi: 10.1038/s41433-022-02241-w. Epub 2022 Sep 14. Eye (Lond). 2023. PMID: 36104524 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources